13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001442756
Total reported value
$1.2B
$1.2B
74 檔
51.9%
The Q3 2024 SEC filing reveals that PFM Health Sciences, LP held a total portfolio value of $1.2B, covering 74 public equity positions.
In Q3 2024, PFM Health Sciences, LP adopted a defensive or profit-taking posture, trimming 25 positions and completely liquidating 14 holdings to manage risk exposure.
In terms of portfolio concentration, the top 5 core holdings (including LLY, THC, CYTK) accounted for 51.9% of total reported equity market value during Q3 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | Stock-Healthcare | 14.99% | -1.48% | — | |
| 2 | THC | Tenet Healthcare CORP | Stock-Healthcare | 5.55% | -4.83% | — | |
| 3 | CYTK | Cytokinetics Inc | Stock-Healthcare | 5.26% | +1.40% | NEW | |
| 4 | ABBV | Abbvie Inc | Stock-Healthcare | 4.52% | — | — | |
| 5 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 3.92% | — | — | |
| 6 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 3.82% | — | — | |
| 7 | MRK | Merck & Co. Inc. | Stock-Healthcare | 3.49% | +1.40% | NEW | |
| 8 | HCA | Hca Healthcare Inc | Stock-Healthcare | 2.88% | -0.49% | — | |
| 9 | UHS | Universal Health Services-b | Stock-Healthcare | 2.78% | — | — | |
| 10 | MCK | Mckesson CORP | Stock-Healthcare | 2.73% | — | — | |
| 11 | ARGX | Argenx Se - Adr | Stock-Healthcare | 2.67% | +0.06% | — | |
| 12 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 2.50% | +1.72% | -37.96% | |
| 13 | ACHC | Acadia Healthcare Co Inc | Stock-Other | 2.47% | +0.09% | +63.31% | |
| 14 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 2.38% | +0.54% | — | |
| 15 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 2.05% | +0.57% | -8.20% | |
| 16 | DHR | Danaher CORP | Stock-Healthcare | 1.98% | — | — | |
| 17 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 1.90% | -5.30% | EXIT | |
| 18 | ICLR | ICON Public Limited Company | Stock-Healthcare | 1.90% | +1.45% | — | |
| 19 | PEN | Penumbra Inc | Stock-Healthcare | 1.83% | -2.56% | -10.18% | |
| 20 | HUM | Humana Inc | Stock-Healthcare | 1.83% | +3.22% | NEW | |
| 21 | ELV | Elevance Health Inc | Stock-Healthcare | 1.66% | — | +2.16% | |
| 22 | AMGN | Amgen Inc | Stock-Healthcare | 1.65% | — | +11.43% | |
| 23 | ASND 2.25 04-01-28Bond | Ascendis Pharma A/s | Bond | 1.52% | -1.54% | EXIT | |
| 24 | IQV | Iqvia Holdings Inc | Stock-Healthcare | 1.50% | — | — | |
| 25 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 1.46% | +0.08% | -47.20% | |
| 26 | BDX | Becton Dickinson And Co | Stock-Healthcare | 1.39% | — | -22.61% | |
| 27 | SYK | Stryker CORP | Stock-Healthcare | 1.37% | +0.87% | -41.37% | |
| 28 | MOH | Molina Healthcare Inc | Stock-Healthcare | 1.37% | — | — | |
| 29 | INSP | Inspire Medical Systems Inc | Stock-Healthcare | 1.18% | — | — | |
| 30 | WAT | Waters CORP | Stock-Healthcare | 1.04% | +0.85% | +148.59% | |
| 31 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 1.03% | +0.75% | — | |
| 32 | EPIEUR | Essa Pharma Inc | Stock-Other | 0.94% | — | -7.50% | |
| 33 | ASND | Ascendis Pharma A/S | Stock-Other | 0.77% | -3.64% | EXIT | |
| 34 | ERAS | Erasca Inc | Stock-Other | 0.75% | +0.21% | NEW | |
| 35 | INSM | Insmed Inc | Stock-Healthcare | 0.63% | — | -36.92% | |
| 36 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 0.62% | — | — | |
| 37 | CELC | Celcuity Inc | Stock-Other | 0.60% | +0.47% | NEW | |
| 38 | PRAX | Praxis Precision Medicines I | Stock-Other | 0.60% | +0.07% | -59.60% | |
| 39 | ADAPY | Adaptimmune Therapeutics-adr | Stock-Other | 0.54% | — | -4.94% | |
| 40 | BSX | Boston Scientific CORP | Stock-Healthcare | 0.52% | — | -68.84% | |
| 41 | SRPT 1.25 09-15-27Bond | Sarepta Therapeutics Inc | Bond | 0.50% | — | — | |
| 42 | CRBU | Caribou Biosciences Inc | Stock-Other | 0.48% | -0.12% | +5.47% | |
| 43 | SNDX | Syndax Pharmaceuticals Inc | Stock-Other | 0.46% | -0.30% | +9.44% | |
| 44 | HOWL | Werewolf Therapeutics Inc | Stock-Other | 0.41% | — | +4.86% | |
| 45 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 0.40% | — | +19.48% | |
| 46 | CON | Concentra Group Holdings Par | Stock-Other | 0.38% | — | — | |
| 47 | KROS | Keros Therapeutics Inc | Stock-Other | 0.33% | — | +202.95% | |
| 48 | ALKS | Alkermes plc | Stock-Healthcare | 0.33% | — | — | |
| 49 | ITCIEUR | Intra-cellular Therapies Inc | Stock-Other | 0.32% | — | -54.59% | |
| 50 | TGTX | Tg Therapeutics Inc | Stock-Healthcare | 0.31% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | THC | Tenet Healthcare CORP | +1.7% | — | Unchanged |
| 2 | LLY | Eli Lilly & Co | +1.6% | — | Unchanged |
| 3 | INSP | Inspire Medical Systems Inc | +1.2% | NEW | New buy |
| 4 | ABBV | Abbvie Inc | +1.1% | — | Unchanged |
| 5 | ACHC | Acadia Healthcare Co Inc | +1.1% | +63.31% | Add |
| 6 | HCA | Hca Healthcare Inc | +0.9% | — | Unchanged |
| 7 | ARGX | Argenx Se - Adr | +0.8% | — | Unchanged |
| 8 | UHS | Universal Health Services-b | +0.8% | — | Unchanged |
| 9 | ISRG | Intuitive Surgical Inc | +0.8% | — | Unchanged |
| 10 | ASND | Ascendis Pharma A/S | +0.8% | NEW | New buy |
| 11 | WAT | Waters CORP | +0.8% | +148.59% | Add |
| 12 | CYTK | Cytokinetics Inc | +0.6% | — | Unchanged |
| 13 | ASND 2.25 04-01-28Bond | Ascendis Pharma A/s | +0.5% | +27.78% | Add |
| 14 | AXSM | Axsome Therapeutics Inc | +0.5% | — | Unchanged |
| 15 | VRTX | Vertex Pharmaceuticals Inc | +0.5% | — | Unchanged |
| 16 | DHR | Danaher CORP | +0.4% | — | Unchanged |
| 17 | AMGN | Amgen Inc | +0.4% | +11.43% | Add |
| 18 | CON | Concentra Group Holdings Par | +0.4% | NEW | New buy |
| 19 | OSCR | Oscar Health Inc - Class A | +0.4% | — | Unchanged |
| 20 | MOH | Molina Healthcare Inc | +0.3% | — | Unchanged |
| 21 | IQV | Iqvia Holdings Inc | +0.3% | — | Unchanged |
| 22 | TGTX | Tg Therapeutics Inc | +0.3% | NEW | New buy |
| 23 | TMO | Thermo Fisher Scientific Inc | +0.3% | -8.20% | Trim |
| 24 | KROS | Keros Therapeutics Inc | +0.3% | +202.95% | Add |
| 25 | VEEV | Veeva Systems Inc-class A | +0.2% | NEW | New buy |
| 26 | ✓ | Longboard Pharmaceuticals In | +0.2% | NEW | New buy |
| 27 | OCUL | Ocular Therapeutix Inc | +0.2% | NEW | New buy |
| 28 | ERAS | Erasca Inc | +0.2% | +4.39% | Add |
| 29 | PEN | Penumbra Inc | +0.2% | -10.18% | Trim |
| 30 | ELV | Elevance Health Inc | +0.2% | +2.16% | Add |
| 31 | LUNG | Pulmonx CORP | +0.2% | NEW | New buy |
| 32 | EPIEUR | Essa Pharma Inc | +0.2% | -7.50% | Trim |
| 33 | CRBU | Caribou Biosciences Inc | +0.2% | +5.47% | Add |
| 34 | CAPR | Capricor Therapeutics Inc | +0.1% | NEW | New buy |
| 35 | ARKG | Ark Genomic Revolution ETF | +0.1% | NEW | New buy |
| 36 | XENE | Xenon Pharmaceuticals Inc | +0.1% | +19.48% | Add |
| 37 | ICLR | ICON Public Limited Company | +0.1% | — | Unchanged |
| 38 | ALKS | Alkermes plc | +0.1% | — | Unchanged |
| 39 | PMVP | Pmv Pharmaceuticals Inc | +0.1% | +57.67% | Add |
| 40 | SNDX | Syndax Pharmaceuticals Inc | +0.1% | +9.44% | Add |
| 41 | ADAPY | Adaptimmune Therapeutics-adr | 0% | -4.94% | Trim |
| 42 | ✓ | Verve Therapeutics Inc | 0% | NEW | New buy |
| 43 | HOWL | Werewolf Therapeutics Inc | 0% | +4.86% | Add |
| 44 | BOLD | Boundless Bio Inc | 0% | +71.17% | Add |
| 45 | INBX | Inhibrx Biosciences Inc | 0% | — | Unchanged |
| 46 | SRPT 1.25 09-15-27Bond | Sarepta Therapeutics Inc | 0% | — | Unchanged |
| 47 | IOVA | Iovance Biotherapeutics Inc | 0% | -13.51% | Trim |
| 48 | DAWNGBX | Day One Biopharmaceuticals I | — | -13.73% | Trim |
| 49 | IOBTQ | Io Biotech Inc | — | — | Unchanged |
| 50 | GBIOGBX | Generation Bio Co | — | — | Unchanged |
According to official SEC Form 13F filings, PFM Health Sciences, LP reported a total U.S. public equity portfolio value of $1.2B across 74 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
INSP
市值: $20.8M
Top Position Liquidated / Trimmed
QQQ
前期市值: $89.8M
During Q3 2024, PFM Health Sciences, LP's top holdings by market value included LLY (15.0%)、THC (5.5%)、CYTK (5.3%). The largest single position, LLY, represented 15.0% of total portfolio value.
In Q3 2024, PFM Health Sciences, LP made 63 total portfolio adjustments, initiating 11 new buys, adding to 13 positions, trimming 25 holdings, and fully liquidating 14 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.